Neogenomics Inc (NASDAQ:NEO)
| 8.16 Delayed Data As of Jun 30 |  -0.17 / -2.04%Today’s Change | 6.85 Today|||52-Week Range 54.74 | -76.08% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Year Trend | |||||
|---|---|---|---|---|---|---|
2015 | 2016 | 2017 | 2018 | |||
| Revenue and Income | Net Revenues | 99.8M | 244.1M | 258.6M | 276.7M | |
| Cost of Goods Sold | 51.8M | 114.9M | 122.0M | 141.3M | ||
| Depreciation And Amortization | 7.1M | 23.2M | 22.6M | 21.7M | ||
| Operating Expenses | Gross Income | 40.9M | 106.0M | 114.0M | 113.7M | |
| General Expenses | 41.8M | 99.9M | 110.6M | 101.4M | ||
| Research And Development | 4.0M | 4.4M | 3.5M | 3.0M | ||
| Total Operating Expenses | 100.7M | 238.0M | 255.2M | 264.4M | ||
| Non-Operating Expenses | Operating Income | -935.0K | 6.0M | 3.4M | 12.3M | |
| Extraordinary Charge | -4.7M | -3.5M | 0.00 | -2.3M | ||
| Interest Expense On Debt | 854.0K | 10.0M | 5.5M | 6.2M | ||
| Other Expenses | 2.0M | 0.00 | -1.3M | 14.0K | ||
| Income Taxes, Minority Interest and Extra Items | Pre-Tax Income | -4.5M | -7.4M | -3.5M | 3.8M | |
| Income Taxes | -2.0M | -1.7M | -2.6M | -1.2M | ||
| Preferred Dividend | -122.0K | -24.7M | -10.5M | -3.4M | ||
| Net Income | -2.5M | -5.7M | -846.0K | 2.6M | ||
| Shares To Calculate EPS | Shares To Calculate EPS | 60.5M | 77.5M | 79.4M | 85.6M | |
| Shares To Calculate EPS Diluted | 60.5M | 77.5M | 79.4M | 91.6M | ||
| Earnings Per Share | EPS | -$0.04 | -$0.39 | -$0.14 | $0.07 | |
| EPS Diluted | -$0.04 | -$0.39 | -$0.14 | $0.07 | ||
